These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21890287)

  • 1. Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae.
    Marchioro SB; Simionatto S; Galli V; Conceição FR; Brum CB; Fisch A; Gomes CK; Dellagostin OA
    Vet Microbiol; 2012 Feb; 155(1):44-52. PubMed ID: 21890287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant secreted antigens from Mycoplasma hyopneumoniae delivered as a cocktail vaccine enhance the immune response of mice.
    Galli V; Simionatto S; Marchioro SB; Klabunde GH; Conceição FR; Dellagostin OA
    Clin Vaccine Immunol; 2013 Sep; 20(9):1370-6. PubMed ID: 23803903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
    de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
    Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins.
    Simionatto S; Marchioro SB; Galli V; Brum CB; Klein CS; Rebelatto R; Silva EF; Borsuk S; Conceição FR; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2012 Mar; 35(2):209-16. PubMed ID: 22304900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and purification of recombinant proteins of Mycoplasma hyopneumoniae expressed in Escherichia coli.
    Simionatto S; Marchioro SB; Galli V; Hartwig DD; Carlessi RM; Munari FM; Laurino JP; Conceição FR; Dellagostin OA
    Protein Expr Purif; 2010 Feb; 69(2):132-6. PubMed ID: 19747547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
    Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
    Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
    Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of swine antigen-specific antibody responses to Mycoplasma hyopneumoniae infection determined by protein microarray.
    Petersen AC; Clampitt JM; Minion FC
    Vet Microbiol; 2019 Mar; 230():195-201. PubMed ID: 30827388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.
    Wang Y; Wang J; Zhou M; Liu P; Zhang E; Li Y; Lin J; Feng Z; Yang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31492763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma hyopneumoniae type I signal peptidase: expression and evaluation of its diagnostic potential.
    Moitinho-Silva L; Heineck BL; Reolon LA; Paes JA; Klein CS; Rebelatto R; Schrank IS; Zaha A; Ferreira HB
    Vet Microbiol; 2012 Jan; 154(3-4):282-91. PubMed ID: 21831542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine antibody profiles of 33 Mycoplasma hyopneumoniae fusion proteins from M. hyopneumoniae natural infection but not vaccination.
    Ning Y; Yang Y; Tian Y; Zhang Y; Luo W; Wen Y; Zhou Y; Ding H
    Vet Med Sci; 2023 Jan; 9(1):203-216. PubMed ID: 36520664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological diagnosis of enzootic pneumonia of swine by a double-sandwich enzyme-linked immunosorbent assay using a monoclonal antibody and recombinant antigen (P46) of Mycoplasma hyopneumoniae.
    Okada M; Asai T; Futo S; Mori Y; Mukai T; Yazawa S; Uto T; Shibata I; Sato S
    Vet Microbiol; 2005 Feb; 105(3-4):251-9. PubMed ID: 15708823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.
    Okamba FR; Moreau E; Cheikh Saad Bouh K; Gagnon CA; Massie B; Arella M
    Clin Vaccine Immunol; 2007 Jun; 14(6):767-74. PubMed ID: 17409219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Immunization with Attenuated
    Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
    Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Mycoplasma hyopneumoniae Recombinant Vaccines.
    Marchioro SB; Simionatto S; Dellagostin O
    Methods Mol Biol; 2016; 1404():39-50. PubMed ID: 27076288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient site-directed mutagenesis using an overlap extension-PCR method for expressing Mycoplasma hyopneumoniae genes in Escherichia coli.
    Simionatto S; Marchioro SB; Galli V; Luerce TD; Hartwig DD; Moreira AN; Dellagostin OA
    J Microbiol Methods; 2009 Oct; 79(1):101-5. PubMed ID: 19733599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and immunological characterization of conserved Mycoplasma hyopneumoniae lipoproteins Mhp378 and Mhp651.
    Meens J; Selke M; Gerlach GF
    Vet Microbiol; 2006 Aug; 116(1-3):85-95. PubMed ID: 16650945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
    Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
    Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoenhancement of Recombinant Neisseria meningitides PorB Protein on Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Genetically Engineered Vaccines.
    Yang R; Tao Y; Li G; Chen J; Shu J; He Y
    Protein Pept Lett; 2019; 26(10):776-784. PubMed ID: 31208304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific monoclonal antibodies to Escherichia coli-expressed p36 cytosolic protein of Mycoplasma hyopneumoniae.
    Caron J; Sawyer N; Ben Abdel Moumen B; Cheikh Saad Bouh K; Dea S
    Clin Diagn Lab Immunol; 2000 Jul; 7(4):528-35. PubMed ID: 10882646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.